Manifestaciones autoinmunes en el linfoma no hodgkiniano
Guerreiro Hernández, Ana María; Villaescusa Blanco, Rinaldo; Morera Barrios, Luz Mireya; Ramón Rodríguez, Luis Gabriel.
Rev. cuba. hematol. inmunol. hemoter
; 22(1)ene.-abr. 2006.
Artículo en Español | LILACS | ID: lil-446828
Documentos relacionados
[Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
[Epigenetic abnormalities in non-Hodgkin lymphomas].
A case of non-Hodgkin lymphoma of the upper gingiva with minimal residual disease detected in cryopreserved ovarian tissue: A case report.
The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
Malnutrition diagnosed by GLIM criteria better predicts long-term outcomes for patients with non-Hodgkin's lymphoma: A prospective multicenter cohort study.
[Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
Environmental pesticide exposure and non-Hodgkin lymphoma survival: a population-based study.